BackJu Fu Tang Biotech Holdings , Ltd Overview

Ju Fu Tang Biotech Holdings , Ltd EBIT

Track Ju Fu Tang Biotech Holdings , Ltd's EBIT ($14M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$4.28M
↓ 408.92% YoY

As of Mar 31, 2026

Annual EBIT (TTM)

$14.39M
↑ 306.4% YoY

Trailing 12 months ending Mar 31, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Ju Fu Tang Biotech Holdings , Ltd (8217.HK) FAQ

As of the most recent data (March 2026), 8217.HK shows a EBIT of $14M. That compares with $-7M in the prior-year period — up 306.4% year over year. That is below the Industrials sector average of $160B. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, 8217.HK's EBIT is now $14M (was $-7M) — a 306.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Ju Fu Tang Biotech Holdings , Ltd is outperforming or lagging.

The Industrials sector average EBIT is about $160B. Ju Fu Tang Biotech Holdings , Ltd is at $14M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how 8217.HK stacks up against individual peers as well.

Tracking 8217.HK's ebit over time shows whether Ju Fu Tang Biotech Holdings , Ltd is scaling, shrinking, or reshaping that part of the business. The current reading is $14M That compares with $-7M in the prior-year period — up 306.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Ju Fu Tang Biotech Holdings , Ltd's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $14M) with ownership activity and broader fundamentals.